References
- Moreau E J, Matutes E, A'Hern R P, Morilla A M, Morilla R M, Owusu-Ankomah K A, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 1997; 108: 378–382
- Muller-Hermelink H K, Catovsky D, Montserrat E, Harris N L. Chronic lymphocytic leukemia/small lymphocytic lymphoma. Tumours of haematopoietic and lymphoid tissues, E Jaffe, N Harris, H Stein, J Vardiman. IARC Press, Lyon 2001; 127–130
- Nowakowski G S, Dewald G W, Hoyer J D, Paternoster S F, Stockero K J, Fink S R, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 36–42
- Ugo V, Leporrier N, Salaun V, Letestu R, Radford-Weiss I, Ramond S, et al. Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006; 47: 2088–2095
- Thompson A, Talley J, Do H, Kagan H, Kunkel L, Berenson J, et al. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 1997; 90: 1387–1394
- Serke S, Schwaner I, Yordanova M, Szczepek A, Huhn D. Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry 2001; 46: 98–104